Biogen Inc. (BIIB) has been falling consistently over the past few weeks. However, we might see a bump next week.Biogen (BIIB) Daily Chart(click to enlarge)Failed Bullish Attempt:- First of all, let's go back a few weeks when BIIB trading in a small range within the larger consolidation range we see on the daily chart.- On 4/25, price broke to the upside on the back of better-than-expected earnings. As Yahoo Finance indicated, "The company surpassed expectations both for earnings and sales."- The market initially bought BIIB and drove it up above 290. However, as we can see on the daily chart, price missed the consolidation resistance and retreated sharply afterwards. - The failure to even test the consolidation resistance was an indication that the market was NOT bullish.Now at Support:- Price not only drove back the gains from the reaction, but pushed price below the aforementioned range. - As we start this week, price is testing a consolidation support around 250.- The chart shows a slight upward tilt to the support, but I would still focus on the November low, around 247 as key support.- The thing is, remember we noted that the bulls showed weakness. Perhaps, we should not rely on support here. Another reason to not buy here is that the dip has been sharp, like a falling knife within the range.- Finally, even if we anticipate support here, we should probably limit our bullish outlook to the middle of the range.- I would say the max bullish outlook from this 250 area would be 270. In conclusion, the price action leading to currently trading at support makes me uncomfortable relying on support here.